Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Articles and issues > Author index
Search
Min Jung Jung 7 Articles
A multicenter study of interobserver variability in pathologic diagnosis of papillary breast lesions on core needle biopsy with WHO classification
Hye Ju Kang, Sun Young Kwon, Ahrong Kim, Woo Gyeong Kim, Eun Kyung Kim, Ae Ree Kim, Chungyeul Kim, Soo Kee Min, So Young Park, Sun Hee Sung, Hye Kyoung Yoon, Ahwon Lee, Ji Shin Lee, Hyang Im Lee, Ho Chang Lee, Sung Chul Lim, Sun Young Jun, Min Jung Jung, Chang Won Jung, Soo Youn Cho, Eun Yoon Cho, Hye Jeong Choi, So Yeon Park, Jee Yeon Kim, In Ae Park, Youngmee Kwon
J Pathol Transl Med. 2021;55(6):380-387.   Published online October 6, 2021
DOI: https://doi.org/10.4132/jptm.2021.07.29
  • 3,077 View
  • 167 Download
  • 1 Citations
AbstractAbstract PDFSupplementary Material
Background
Papillary breast lesions (PBLs) comprise diverse entities from benign and atypical lesions to malignant tumors. Although PBLs are characterized by a papillary growth pattern, it is challenging to achieve high diagnostic accuracy and reproducibility. Thus, we investigated the diagnostic reproducibility of PBLs in core needle biopsy (CNB) specimens with World Health Organization (WHO) classification.
Methods
Diagnostic reproducibility was assessed using interobserver variability (kappa value, κ) and agreement rate in the pathologic diagnosis of 60 PBL cases on CNB among 20 breast pathologists affiliated with 20 medical institutions in Korea. This analysis was performed using hematoxylin and eosin (H&E) staining and immunohistochemical (IHC) staining for cytokeratin 5 (CK5) and p63. The pathologic diagnosis of PBLs was based on WHO classification, which was used to establish simple classifications (4-tier, 3-tier, and 2-tier).
Results
On WHO classification, H&E staining exhibited ‘fair agreement’ (κ = 0.21) with a 47.0% agreement rate. Simple classifications presented improvement in interobserver variability and agreement rate. IHC staining increased the kappa value and agreement rate in all the classifications. Despite IHC staining, the encapsulated/solid papillary carcinoma (EPC/SPC) subgroup (κ = 0.16) exhibited lower agreement compared to the non-EPC/SPC subgroup (κ = 0.35) with WHO classification, which was similar to the results of any other classification systems.
Conclusions
Although the use of IHC staining for CK5 and p63 increased the diagnostic agreement of PBLs in CNB specimens, WHO classification exhibited a higher discordance rate compared to any other classifications. Therefore, this result warrants further intensive consensus studies to improve the diagnostic reproducibility of PBLs with WHO classification.

Citations

Citations to this article as recorded by  
  • High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision
    Aparna Harbhajanka, Hannah L. Gilmore, Benjamin C. Calhoun
    Modern Pathology.2022; 35(11): 1500.     CrossRef
Malignant rhabdoid tumor of the kidney in an adult with loss of INI1 expression and mutation in the SMARCB1 gene
Eunkyung Han, Jiyoon Kim, Min Jung Jung, Susie Chin, Sang Wook Lee, Ahrim Moon
J Pathol Transl Med. 2021;55(2):145-153.   Published online March 9, 2021
DOI: https://doi.org/10.4132/jptm.2021.01.26
  • 1,857 View
  • 86 Download
AbstractAbstract PDF
A 57-year-old man with left flank pain was referred to our institute. Computed tomography scans revealed two enhancing masses in the left kidney. The clinical diagnosis was renal cell carcinoma (RCC). He underwent a radical nephrectomy with an adrenalectomy. Two well-circumscribed solid masses in the hilum and the lower pole (4.5 × 3.5 cm and 7.0 × 4.1 cm) were present. Poorly cohesive uniform round to polygonal epithelioid cells making solid sheets accounted for most of the tumor area. The initial diagnosis was RCC, undifferentiated with rhabdoid features. As the tumor showed loss of INI1 expression and a mutation in the SMARCB1 gene on chromosome 22, the revised diagnosis was a malignant rhabdoid tumor (MRT) of the kidney. To date, only a few cases of renal MRT in adults have been reported. To the best of our knowledge, this is the first report of MRT in the native kidney of an adult demonstrating a SMARCB1 gene mutation, a hallmark of MRT.
Loss of Nuclear BAP1 Expression Is Associated with High WHO/ISUP Grade in Clear Cell Renal Cell Carcinoma
Young Chan Wi, Ahrim Moon, Min Jung Jung, Yeseul Kim, Seong Sik Bang, Kiseok Jang, Seung Sam Paik, Su-Jin Shin
J Pathol Transl Med. 2018;52(6):378-385.   Published online October 1, 2018
DOI: https://doi.org/10.4132/jptm.2018.09.21
  • 6,321 View
  • 182 Download
  • 10 Citations
AbstractAbstract PDF
Background
BRCA1-associated protein 1 (BAP1) mutations are frequently reported in clear cell renal cell carcinoma (ccRCC); however, very few studies have evaluated the role of these mutations in other renal cell carcinoma (RCC) subtypes. Therefore, we analyzed BAP1 protein expression using immunohistochemistry in several RCC subtypes and assessed its relationship with clinicopathological characteristics of patients.
Methods
BAP1 expression was immunohistochemically evaluated in tissue microarray blocks constructed from 371 samples of RCC collected from two medical institutions. BAP1 expression was evaluated based on the extent of nuclear staining in tumor cells, and no expression or expression in < 10% of tumor cells was defined as negative.
Results
Loss of BAP1 expression was observed in ccRCC (56/300, 18.7%), chromophobe RCC (6/26, 23.1%), and clear cell papillary RCC (1/4, 25%), while we failed to detect BAP1 expression loss in papillary RCC, acquired cystic disease-associated RCC, or collecting duct carcinoma. In ccRCC, loss of BAP1 expression was significantly associated with high World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grade (p = .002); however, no significant correlation was observed between loss of BAP1 expression and survival in ccRCC. Loss of BAP1 expression showed no association with prognostic factors in chromophobe RCC.
Conclusions
Loss of BAP1 nuclear expression was observed in both ccRCC and chromophobe RCC. In addition, BAP1 expression loss was associated with poor prognostic factors such as high WHO/ISUP grade in ccRCC.

Citations

Citations to this article as recorded by  
  • Immunohistochemistry for the diagnosis of renal epithelial neoplasms
    Mahmut Akgul, Sean R Williamson
    Seminars in Diagnostic Pathology.2022; 39(1): 1.     CrossRef
  • BRCA1-Associated Protein 1 (BAP-1) as a Prognostic and Predictive Biomarker in Clear Cell Renal Cell Carcinoma: A Systematic Review
    Shuchi Gulati, Melissa Previtera, Primo N. Lara
    Kidney Cancer.2022; 6(1): 23.     CrossRef
  • Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update
    Ziad M. El-Zaatari, Luan D. Truong
    Biomedicines.2022; 10(3): 657.     CrossRef
  • CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma
    Mounika Angirekula, Sindy Y Chang, Sarah M. Jenkins, Patricia T. Greipp, William R. Sukov, Randolph S. Marks, Kenneth R. Olivier, Stephen D. Cassivi, Anja C Roden
    Cancers.2022; 14(9): 2299.     CrossRef
  • BAP1 in cancer: epigenetic stability and genome integrity
    Sabrina Caporali, Alessio Butera, Ivano Amelio
    Discover Oncology.2022;[Epub]     CrossRef
  • Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma
    Xiaoqin Zhang, Ziyue Wang, Zixin Zeng, Ningning Shen, Bin Wang, Yaping Zhang, Honghong Shen, Wei Lu, Rong Wei, Wenxia Ma, Chen Wang
    Cancer Cell International.2021;[Epub]     CrossRef
  • Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
    Dengyong Xu, Yuzi Xu, Yiming Lv, Fei Wu, Yunlong Liu, Ming Zhu, Dake Chen, Bingjun Bai
    BioMed Research International.2020; 2020: 1.     CrossRef
  • Functional characterisation guides classification of novel BAP1 germline variants
    Jing Han Hong, Siao Ting Chong, Po-Hsien Lee, Jing Tan, Hong Lee Heng, Nur Diana Binte Ishak, Sock Hoai Chan, Bin Tean Teh, Joanne Ngeow
    npj Genomic Medicine.2020;[Epub]     CrossRef
  • Tissue-Based Immunohistochemical Markers for Diagnosis and Classification of Renal Cell Carcinoma
    Liang G Qu, Vaisnavi Thirugnanasundralingam, Damien Bolton, Antonio Finelli, Nathan Lawrentschuk
    Société Internationale d’Urologie Journal.2020; 1(1): 68.     CrossRef
  • Radiogenomics: bridging imaging and genomics
    Zuhir Bodalal, Stefano Trebeschi, Thi Dan Linh Nguyen-Kim, Winnie Schats, Regina Beets-Tan
    Abdominal Radiology.2019; 44(6): 1960.     CrossRef
The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
Jee Soon Kim, Youn Soo Lee, Min Jung Jung, Yong Kil Hong
J Pathol Transl Med. 2016;50(6):419-425.   Published online October 6, 2016
DOI: https://doi.org/10.4132/jptm.2016.06.30
  • 6,934 View
  • 224 Download
  • 16 Citations
AbstractAbstract PDF
Background
The 2004 World Health Organization classification introduced atypical pituitary adenoma (aPA), which was equivocally defined as invasion with increased mitotic activity that had a Ki-67 labeling index (LI) greater than 3%, and extensive p53 immunoreactivity. However, aPAs that exhibit all of these features are rare and the predictive value for recurrence in pituitary adenomas (PAs) remains uncertain. Thus, we sought to characterize pathological features of PAs that correlated with recurrence.
Methods
One hundred and sixty-seven cases of surgically resected PA or aPA were retrieved from 2011 to 2013 in Seoul St. Mary’s Hospital. Among them, 28 cases were confirmed to be recurrent, based on pathologic or radiologic examination. The pathologic characteristics including mitosis, invasion, Ki-67 LI and p53 immunoreactivity were analyzed in relation to recurrence.
Results
Analysis of the pathologic features indicated that only Ki-67 LI over 3% was significantly associated with tumor recurrence (p = .02). The cases with at least one pathologic feature showed significantly higher recurrence rates (p < .01). Analysis indicated that cases with two pathologic features, Ki-67 LI over 3% and extensive p53 immunoreactivity 20% or more, were significantly associated with tumor recurrence (p < .01).
Conclusions
Based on these results, PA tumor recurrence can be predicted by using mitosis, invasion, Ki-67 LI (3%), or extensive p53 immunoreactivity (≥ 20%). Assessment of these features is recommended for PA diagnosis for more accurate prediction of recurrence.

Citations

Citations to this article as recorded by  
  • Ki-67/MIB-1 and Recurrence in Pituitary Adenoma
    Kent Tadokoro, Colten Wolf, Joseph Toth, Cara Joyce, Meharvan Singh, Anand Germanwala, Chirag Patel
    Journal of Neurological Surgery Part B: Skull Base.2022; 83(S 02): e580.     CrossRef
  • Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas
    Su Jung Kum, Hye Won Lee, Soon Gu Kim, Hyungsik Park, Ilseon Hwang, Sang Pyo Kim
    Journal of Pathology and Translational Medicine.2022; 56(1): 22.     CrossRef
  • A Preoperative MRI-Based Radiomics-Clinicopathological Classifier to Predict the Recurrence of Pituitary Macroadenoma Within 5 Years
    Yu Zhang, Yuqi Luo, Xin Kong, Tao Wan, Yunling Long, Jun Ma
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent Tumors
    Anne-Laure Bernat, Pénélope Troude, Stefano Maria Priola, Ahmad Elsawy, Faisal Farrash, Ozgur Mete, Shereen Ezzat, Sylvia L. Asa, John De Almeida, Allan Vescan, Eric Monteiro, Joao Paulo Almeida, Gelareh Mohammed Zadeh, Fred Gentili
    World Neurosurgery.2021; 146: e341.     CrossRef
  • A Nomogram for Preoperatively Predicting the Ki-67 Index of a Pituitary Tumor: A Retrospective Cohort Study
    Xiangming Cai, Junhao Zhu, Jin Yang, Chao Tang, Feng Yuan, Zixiang Cong, Chiyuan Ma
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Comparative Proteomic Study Shows the Expression of Hint-1 in Pituitary Adenomas
    Carolina Carrillo-Najar, Daniel Rembao-Bojórquez, Martha L. Tena-Suck, Sergio Zavala-Vega, Noemí Gelista-Herrera, Miguel A. Ramos-Peek, Juan L. Gómez-Amador, Febe Cazares-Raga, Fidel de la Cruz Hernández-Hernández, Alma Ortiz-Plata
    Diagnostics.2021; 11(2): 330.     CrossRef
  • Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging
    Ching-Chung Ko, Tai-Yuan Chen, Sher-Wei Lim, Yu-Ting Kuo, Te-Chang Wu, Jeon-Hor Chen
    Journal of Neurosurgery.2020; 132(2): 351.     CrossRef
  • Pituitary tumors: epidemiology and clinical presentation spectrum
    Marta Araujo-Castro, Víctor Rodríguez Berrocal, Eider Pascual-Corrales
    Hormones.2020; 19(2): 145.     CrossRef
  • Ki67 in endocrine neoplasms: to count or not to count, this is the question! A systematic review from the English language literature
    E. Guadagno, E. D’Avella, P. Cappabianca, A. Colao, M. Del Basso De Caro
    Journal of Endocrinological Investigation.2020; 43(10): 1429.     CrossRef
  • Study of Simple Immunohistochemical Cytocolorimetric Assay Application for More Accurate Assessment of Prognosis in Patients with Pituitary Adenomas
    Pavel V. Nikitin, Marina V. Ryzhova, Lyudmila V. Shishkina, Svetlana V. Shugay, Irina V. Zubova
    World Neurosurgery.2019; 122: e1047.     CrossRef
  • The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas
    Rovshan Hasanov, Berna İmge Aydoğan, Saba Kiremitçi, Esra Erden, Sevim Güllü
    Endocrine Pathology.2019; 30(1): 49.     CrossRef
  • Residual Tumor Confers a 10-Fold Increased Risk of Regrowth in Clinically Nonfunctioning Pituitary Tumors
    Jelena Maletkovic, Asmaa Dabbagh, Dongyun Zhang, Abdul Zahid, Marvin Bergsneider, Marilene B Wang, Michael Linetsky, Noriko Salamon, William H Yong, Harry V Vinters, Anthony P Heaney
    Journal of the Endocrine Society.2019; 3(10): 1931.     CrossRef
  • Atypical pituitary adenoma: a clinicopathologic case series
    Martin J. Rutkowski, Ryan M. Alward, Rebecca Chen, Jeffrey Wagner, Arman Jahangiri, Derek G. Southwell, Sandeep Kunwar, Lewis Blevins, Han Lee, Manish K. Aghi
    Journal of Neurosurgery.2018; 128(4): 1058.     CrossRef
  • Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients
    Julie Lelotte, Anne Mourin, Edward Fomekong, Alex Michotte, Christian Raftopoulos, Dominique Maiter
    European Journal of Endocrinology.2018; 178(3): 237.     CrossRef
  • Letter to the Editor. Atypical pituitary adenoma
    Lauren E. Rotman, T. Brooks Vaughan, James R. Hackney, Kristen O. Riley
    Journal of Neurosurgery.2018; 129(6): 1657.     CrossRef
  • Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies
    Anna Angelousi, Georgios K Dimitriadis, Georgios Zografos, Svenja Nölting, Gregory Kaltsas, Ashley Grossman
    Endocrine-Related Cancer.2017; 24(6): R239.     CrossRef
A Case of Metastatic Angiosarcoma Diagnosed by Liquid-Based Preparation: Peculiar Cytoplasmic Changes
Min Jung Jung, Young Ok Kim
Korean J Pathol. 2014;48(3):241-247.   Published online June 26, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.3.241
  • 5,621 View
  • 35 Download
  • 3 Citations
AbstractAbstract PDF

Angiosarcoma with predominantly epithelioid features is a rare soft tissue neoplasm and the interpretation of its cytopathologic findings may be difficult. We report a case of metastatic angiosarcoma with predominantly epithelioid features diagnosed by liquid-based cytology. The cytopathologic findings in this case differed from those of the conventional preparation and we found a clean background, no hyperchromatic nuclei and several cytoplasmic changes, including intracytoplasmic vacuoles with peculiar shapes, juxtanuclear condensation and perinuclear clearing. Identification of these changes using liquid-based cytology supplemented with immunochemistry may be helpful in reaching a correct cytopathologic diagnosis.

Citations

Citations to this article as recorded by  
  • Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion
    Hirokazu Ogino, Makoto Tobiume, Kozo Kagawa, Hiroshi Kawano, Satoshi Sakaguchi, Atsuro Saijo, Daisuke Matsumoto, Hiromitsu Takizawa, Yuriko Morikawa, Yoshimi Bando, Hisatsugu Goto, Hiroshi Nokihara, Yasuhiko Nishioka
    Internal Medicine.2022; 61(9): 1393.     CrossRef
  • Delayed diagnosis of angiosarcoma of the spleen: clinically presenting as recurrent haemoperitoneum following embolisation
    V. Kornmann, P. van Rijn, D. Mulder, K. Reijnders
    Case Reports.2015; 2015(apr09 1): bcr2014208956.     CrossRef
  • A Case of Angiosarcoma of the Scalp with Invasion to the Pleural Effusion
    Yusuke Amano, Yukari Obana, Yoko Nakanishi, Ryusuke Tsujimura, Kayomi Wakamatsu, Fumiko Uemura, Yoshihisa Katsura, Masahiko Sugitani, Norimichi Nemoto
    Journal of Nihon University Medical Association.2015; 74(3): 113.     CrossRef
Prognostic Significance of Absolute Lymphocyte Count/Absolute Monocyte Count Ratio at Diagnosis in Patients with Multiple Myeloma
Su-Jin Shin, Jin Roh, Misung Kim, Min Jung Jung, Young Wha Koh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh, Chan-Jeong Park, Hyun Sook Chi, Jooryung Huh
Korean J Pathol. 2013;47(6):526-533.   Published online December 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.6.526
  • 9,974 View
  • 62 Download
  • 21 Citations
AbstractAbstract PDF
Background

Absolute lymphocyte count (ALC) in peripheral blood has recently been reported to be an independent prognostic factor in multiple myeloma (MM). Previous studies indicated that the absolute monocyte count (AMC) in peripheral blood reflects the state of the tumor microenvironment in lymphomas. Neither the utility of the AMC nor its relationship with ALC has been studied in MM.

Methods

The prognostic value of ALC, AMC, and the ALC/AMC ratio at the time of diagnosis was retrospectively examined in 189 patients with MM.

Results

On univariate analysis, low ALC (<1,400 cells/µL), high AMC (≥490 cells/µL), and low ALC/AMC ratio (<2.9) were correlated with worse overall survival (OS) (p=.002, p=.038, and p=.001, respectively). On multivariate analysis, the ALC/AMC ratio was an independent prognostic factor (p=.047), whereas ALC and AMC were no longer statistical significant. Low ALC, high AMC, and low ALC/AMC ratio were associated with poor prognostic factors such as high International Staging System stage, plasmablastic morphology, hypoalbuminemia, and high β2-microglobulin.

Conclusions

Univariate analysis demonstrated that changes in ALC, AMC, and the ALC/AMC ratio are associated with patient survival in MM. Multivariate analysis showed that, of these factors, the ALC/AMC ratio was an independent prognostic factor for OS.

Citations

Citations to this article as recorded by  
  • Normal Absolute Monocyte Count in Combination with Normal/High Absolute Lymphocyte Count at the Time of Relapse is Associated with Improved Survival in Patients with Early Relapsed Acute Myeloid Leukemia
    Yu Zhang, Kanchun Dai, Qianying Zhang, Yisha Huang, Yiyun Feng, Deeksha Bhardwaj, Kang Yu, Jianhua Feng
    Cancer Investigation.2021; 39(6-7): 550.     CrossRef
  • Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
    Francesca Cottini, Ying Huang, Nita Williams, Naresh Bumma, Abdullah M. Khan, Maria Chaudhry, Srinivas Devarakonda, Yvonne A. Efebera, Don M. Benson, Ashley E. Rosko
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
    Xinwen Zhang, Jialin Duan, Zhenyu Wen, Hao Xiong, Xiaomin Chen, Yang Liu, Kunyu Liao, Chunlan Huang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant
    Karen Sweiss, Jonathan Lee, Nadim Mahmud, Gregory S. Calip, Youngmin Park, Dolores Mahmud, Damiano Rondelli, Pritesh R. Patel
    Bone Marrow Transplantation.2020; 55(1): 199.     CrossRef
  • Low absolute CD4+ T cell counts in peripheral blood predict poor prognosis in patients with newly diagnosed multiple myeloma
    Yan Gu, Yuanyuan Jin, Jie Ding, Wu Yujie, Qinglin Shi, Xiaoyan Qu, Sishu Zhao, Jianyong Li, Chen Lijuan
    Leukemia & Lymphoma.2020; 61(8): 1869.     CrossRef
  • Normal Absolute Monocyte Count at the Time of Relapse is Associated with Improved Survival After First Salvage Therapy in Adult Patients with Early Relapsed B-Lineage Acute Lymphoblastic Leukemia


    Yi-fen Shi, Na Wang, Zi-yang Huang, Rong-rong Chen, Yi-sha Huang, Yi-yi Zhu, Chong-yun Xing, Bin Liang, Kang Yu, Jian-hua Feng
    Cancer Management and Research.2020; Volume 12: 7097.     CrossRef
  • Effect of absolute monocyte count post-transplant on the outcome of patients with acute myeloid leukemia undergoing myeloablative allogeneic hematopoietic stem cell transplant with busulfan and cyclophosphamide conditioning
    Liyuan Tang, Na Wang, Chongyun Xing, Qiang Zhuang, Bin Liang, Lan Sun, Yi Chen, Yan Qian, Zhijian Shen, Songfu Jiang, Kang Yu, Jianhua Feng
    Leukemia Research.2018; 69: 60.     CrossRef
  • A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified
    Qian Li, Shuang Gao, Jing Ma, Su Liu, Yuanfang Yue, Lin Chen, Han Li, Xue Wang, Dongying Li, Zeng Cao, Zhigang Zhao, Xiaofang Wang, Yong Yu, Yizhuo Zhang, Yafei Wang
    Leukemia Research.2018; 73: 5.     CrossRef
  • Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma
    Ying Tian, Yue Zhang, Wan-Qiu Zhu, Xiao-Lei Chen, He-Bing Zhou, Wen-Ming Chen
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma
    Moritz Binder, S. Vincent Rajkumar, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Angela Dispenzieri, Yi L. Hwa, Amie Fonder, Miriam Hobbs, Suzanne R. Hayman, Steven R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronal
    American Journal of Hematology.2018;[Epub]     CrossRef
  • Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma
    T Dosani, F Covut, R Beck, J J Driscoll, M de Lima, E Malek
    Blood Cancer Journal.2017; 7(6): e579.     CrossRef
  • Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma
    Gurshawn Singh, Ammar Nassri, David Kim, Hong Zhu, Zeeshan Ramzan
    World Journal of Gastrointestinal Pharmacology and Therapeutics.2017; 8(1): 60.     CrossRef
  • Bone marrow microenvironmental CD4 + and CD8 + lymphocyte infiltration patterns define overall- and progression free survival in standard risk multiple myeloma – an analysis from the Austrian Myeloma Registry
    Wolfgang Willenbacher, Ella Willenbacher, Claudia Zelle-Rieser, Rainer Biedermann, Roman Weger, Karin Jöhrer, Andrea Brunner
    Leukemia & Lymphoma.2016; 57(6): 1478.     CrossRef
  • Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients
    C. Suriu, L. Akria, D. Azoulay, E. Shaoul, M. Barhoum, A. Braester
    International Journal of Laboratory Hematology.2016; 38(3): e56.     CrossRef
  • The Peripheral Blood Mononuclear Cell Count Is Associated With Bone Health in Elderly Men
    Xianfeng Lin, Hejun Yu, Chenchen Zhao, Yu Qian, Dun Hong, Kangmao Huang, Jian Mo, An Qin, Xiangqian Fang, Shunwu Fan
    Medicine.2016; 95(15): e3357.     CrossRef
  • Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis
    Liangyou Gu, Hongzhao Li, Luyao Chen, Xin Ma, Xintao Li, Yu Gao, Yu Zhang, Yongpeng Xie, Xu Zhang
    Oncotarget.2016; 7(22): 31926.     CrossRef
  • Do lymphocytes count in myeloma? Are we absolutely sure?
    Tamar Tadmor
    Leukemia & Lymphoma.2015; 56(5): 1193.     CrossRef
  • Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs
    Mariasanta Napolitano, Giorgia Saccullo, Roberto Bono, Antonio Branca, Clotilde Cangialosi, Salvatrice Mancuso, Simona Raso, Gerlando Quintini, Maria Grazia Lipari, Francesco Fabbiano, Giorgina Specchia, Alberto Dolce, Francesco Di Raimondo, Sergio Siragu
    Leukemia & Lymphoma.2015; 56(5): 1507.     CrossRef
  • Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
    Vivek Naranbhai, Helen A. Fletcher, Rachel Tanner, Matthew K. O'Shea, Helen McShane, Benjamin P. Fairfax, Julian C. Knight, Adrian V.S. Hill
    EBioMedicine.2015; 2(11): 1619.     CrossRef
  • Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia
    László Szerafin, János Jakó, Ferenc Riskó
    Orvosi Hetilap.2015; 156(15): 592.     CrossRef
  • The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer
    Michael Stotz, Joanna Szkandera, Tatjana Stojakovic, Julia Seidel, Hellmut Samonigg, Peter Kornprat, Renate Schaberl-Moser, Fridericke Seggewies, Gerald Hoefler, Armin Gerger, Martin Pichler
    Clinical Chemistry and Laboratory Medicine (CCLM).2015;[Epub]     CrossRef
Finding and Characterizing Mammary Analogue Secretory Carcinoma of the Salivary Gland
Min Jung Jung, Joon Seon Song, Sang Yoon Kim, Soon Yuhl Nam, Jong-Lyel Roh, Seung-Ho Choi, Sung-Bae Kim, Kyung-Ja Cho
Korean J Pathol. 2013;47(1):36-43.   Published online February 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.1.36
  • 11,231 View
  • 89 Download
  • 67 Citations
AbstractAbstract PDF
Background

A new tumor entity of the salivary glands, mammary analogue secretory carcinoma (MASC) with ETV6-NTRK3 translocation, has recently been proposed. MASC was originally diagnosed as adenocarcinoma, not otherwise specified (ANOS), or acinic cell carcinoma (AciCC) by the current World Health Organization classification. We aimed to identify MASC cases by molecular tests, and to characterize their clinical, histological, and immunohistochemical features.

Methods

Thirty cases of MASC candidates were selected after review of 196 salivary gland tumors, and subjected to break-apart ETV6 fluorescence in situ hybridization (FISH), and immunohistochemical study for S100 protein, gross cystic disease fluid protein 15, DOG1, estrogen receptor, and progesterone receptor.

Results

Valid FISH results were obtained in 23 cases, and 13 positive cases were retrieved. MASCs were histologically varied, and the most frequent features observed in 10 cases were low-grade papillary/cystic/glandular patterns, intraluminal secretory materials, ovoid/wrinkled nuclei, and relatively abundant granular eosinophilic cytoplasms, corresponding to papillary-cystic or follicular types of AciCC. All cases showed diffuse immunopositivity for S100 protein. Three cases developed recurrences, but all patients remained alive.

Conclusions

MASC could be a molecularly well-defined salivary gland neoplasm, encompassing some portions of AciCC and ANOS, but its histological spectrum and clinical implication require further investigation.

Citations

Citations to this article as recorded by  
  • Metastatic salivary gland mammary analogue secretory carcinoma (MASC) of parotid gland – A rare case report in the literature review
    Aynur Aliyeva, Ziya Karimov, Togay Muderris
    Acta Oto-Laryngologica Case Reports.2023; 8(1): 38.     CrossRef
  • An Underappreciated Cytomorphological Feature of Secretory Carcinoma of Salivary Gland on Fine Needle Aspiration Biopsy: Case Report with Literature Review
    Yinan Hua, Bing Leng, Kenneth E. Youens, Lina Liu
    Head and Neck Pathology.2022; 16(2): 567.     CrossRef
  • Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report
    Kensuke Suzuki, Hiroshi Harada, Masayuki Takeda, Chisato Ohe, Yoshiko Uemura, Akihiko Kawahara, Shunsuke Sawada, Akira Kanda, Bhaswati Sengupta, Hiroshi Iwai
    BMC Medical Genomics.2022;[Epub]     CrossRef
  • DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis
    Vincenzo Fiorentino, Patrizia Straccia, Pietro Tralongo, Teresa Musarra, Francesco Pierconti, Maurizio Martini, Guido Fadda, Esther Diana Rossi, Luigi Maria Larocca
    International Journal of Molecular Sciences.2022; 23(17): 9711.     CrossRef
  • Secretory carcinoma of the sinonasal cavity and pharynx: A retrospective analysis of four cases and literature review
    Changli Yue, Xiaoli Zhao, Donglin Ma, Yingshi Piao
    Annals of Diagnostic Pathology.2022; 61: 152052.     CrossRef
  • Secretory carcinoma of the salivary gland: a multi‐institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors
    Bin Xu, Kartik Viswanathan, Kavita Umrau, Thair A. D. Al‐Ameri, Snjezana Dogan, Kelly Magliocca, Ronald A. Ghossein, Nicole A. Cipriani, Nora Katabi
    Histopathology.2022; 81(5): 670.     CrossRef
  • A systematic review of secretory carcinoma of the salivary gland: where are we?
    Lísia Daltro Borges Alves, Andreia Cristina de Melo, Thayana Alves Farinha, Luiz Henrique de Lima Araujo, Leandro de Souza Thiago, Fernando Luiz Dias, Héliton Spíndola Antunes, Ana Lucia Amaral Eisenberg, Luiz Claudio Santos Thuler, Daniel Cohen Goldember
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2021; 132(4): e143.     CrossRef
  • A case report of surgical resection of secretory carcinoma in the maxillary and ethmoid sinus
    Kurt Willis, Martin Bullock, Matthew H. Rigby
    International Journal of Surgery Case Reports.2021; 81: 105750.     CrossRef
  • High‐grade salivary gland carcinoma with the ETV6‐NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high‐grade transformation
    Satsuki Asai, Shinji Sumiyoshi, Yosuke Yamada, Ichiro Tateya, Toshitaka Nagao, Sachiko Minamiguchi, Hironori Haga
    Pathology International.2021; 71(6): 427.     CrossRef
  • High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance
    Alena Skalova, Ilmo Leivo, Henrik Hellquist, Abbas Agaimy, Roderick H.W. Simpson, Göran Stenman, Vincent Vander Poorten, Justin A. Bishop, Alessandro Franchi, Juan C. Hernandez-Prera, David Slouka, Stefan M. Willems, Kerry D. Olsen, Alfio Ferlito
    Advances in Anatomic Pathology.2021; 28(3): 107.     CrossRef
  • Radiological features of head and neck mammary analogue secretory carcinoma: 11 new cases with a systematic review of 29 cases reported in 28 publications
    Ryo Kurokawa, Mariko Kurokawa, Akira Baba, Yoshiaki Ota, Toshio Moritani, Ashok Srinivasan
    Neuroradiology.2021; 63(11): 1901.     CrossRef
  • A case of secretory carcinoma of the salivary glands in the lower lip
    Reiko OHARA, Haruki SATO, Kensuke NAGANAWA, Taihei HAYAKAWA, Tatsuya KATAOKA, Ichiro OH-IWA
    Japanese Journal of Oral and Maxillofacial Surgery.2021; 67(2): 83.     CrossRef
  • Undifferentiated and dedifferentiated head and neck carcinomas
    Alessandro Franchi, Alena Skalova
    Seminars in Diagnostic Pathology.2021; 38(6): 127.     CrossRef
  • Cytopathological Findings of Secretory Carcinoma of the Salivary Gland and the Diagnostic Utility of Giemsa Staining
    Yuria Egusa, Midori Filiz Nishimura, Satoko Baba, Kengo Takeuchi, Takuma Makino, Tomoyasu Tachibana, Asami Nishikori, Azusa Fujita, Hiroyuki Yanai, Yasuharu Sato
    Diagnostics.2021; 11(12): 2284.     CrossRef
  • Diagnosis and treatment of secretory carcinoma arising from the oral minor salivary gland
    Masaru Ogawa, Satoshi Yokoo, Takahiro Yamaguchi, Keisuke Suzuki, Mai Seki-Soda, Takahiro Shimizu, Jun Kurihara, Takaya Makiguchi
    Medicine.2021; 100(51): e28390.     CrossRef
  • A biphasic sessile mass of the buccal mucosa
    Tiffany M. Peters, James A. Phero, Brent A. Golden, Alice E. Curran
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2020; 130(6): 612.     CrossRef
  • Don't stop the champions of research now: a brief history of head and neck pathology developments
    Lester D.R. Thompson, James S. Lewis, Alena Skálová, Justin A. Bishop
    Human Pathology.2020; 95: 1.     CrossRef
  • High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene
    Hyun Lee, Jong-Lyel Roh, Young-Jun Choi, Jene Choi, Kyung-Ja Cho
    Head and Neck Pathology.2020; 14(3): 822.     CrossRef
  • Pan‐Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6 – NTRK3 fusion
    Bin Xu, Mohamed R Haroon Al Rasheed, Cristina R Antonescu, Deepu Alex, Denise Frosina, Ronald Ghossein, Achim A Jungbluth, Nora Katabi
    Histopathology.2020; 76(3): 375.     CrossRef
  • Characterization of novel genetic alterations in salivary gland secretory carcinoma
    Kiyong Na, Juan C. Hernandez-Prera, Jae-Yol Lim, Ha Young Woo, Sun Och Yoon
    Modern Pathology.2020; 33(4): 541.     CrossRef
  • Mammary analogue secretory carcinoma: An Indian experience of a novel entity
    Zeba Nisar, JaydeepN Pol, RakhiV Jagdale, MadhuraD Phadke, GirishA Kadkol
    Indian Journal of Pathology and Microbiology.2020; 63(5): 134.     CrossRef
  • Secretory Carcinoma of Salivary Gland with High-Grade Histology Arising in Hard Palate: A Case Report
    Kiyofumi Takabatake, Keisuke Nakano, Hotaka Kawai, Saori Yoshida, Haruka Omori, May Wathone Oo, Shan Qiusheng, Kenichiro Uchida, Katsuaki Mishima, Hitoshi Nagatsuka
    Reports — Medical Cases, Images, and Videos.2020; 3(2): 6.     CrossRef
  • Secretory carcinoma of the salivary gland (mammary analogue secretory carcinoma) in children
    I. V. Sidorov, I. S. Kletskaya, D. M. Konovalov
    Arkhiv patologii.2020; 82(2): 43.     CrossRef
  • Secretory carcinoma of the major salivary gland: Provincial population‐based analysis of clinical behavior and outcomes
    Gareth Ayre, Martin Hyrcza, Jonn Wu, Eric Berthelet, Alena Skálová, Tom Thomson
    Head & Neck.2019; 41(5): 1227.     CrossRef
  • Higher Ki67 Index, Nodal Involvement, and Invasive Growth Were High Risk Factors for Worse Prognosis in Conventional Mammary Analogue Secretory Carcinoma
    Jingjing Sun, Lizhen Wang, Zhen Tian, Yuhua Hu, Ronghui Xia, Jiang Li
    Journal of Oral and Maxillofacial Surgery.2019; 77(6): 1187.     CrossRef
  • Mammary analogue secretory carcinoma of salivary gland diagnosed on submandibular gland cytology: A case report and review of the literature
    Ethar Al‐Husseinawi, Soheila Hamidpour, Evanthia Omoscharka
    Cytopathology.2019; 30(3): 318.     CrossRef
  • Secretory Carcinoma of Minor Salivary Gland in Buccal Mucosa: A Case Report and Review of the Literature
    Durga Paudel, Michiko Nishimura, Bhoj Raj Adhikari, Daichi Hiraki, Aya Onishi, Tetsuro Morikawa, Puja Neopane, Sarita Giri, Koki Yoshida, Jun Sato, Masayuki Ono, Yoshitaka Kamino, Hiroki Nagayasu, Yoshihiro Abiko
    Case Reports in Pathology.2019; 2019: 1.     CrossRef
  • Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma
    Ana Amélia de Souza, Albina Altemani, Ney Soares de Araujo, Lucas Novaes Texeira, Vera Cavalcanti de Araújo, Andresa Borges Soares
    Clinical Pathology.2019; 12: 2632010X1987338.     CrossRef
  • Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications
    Bin Xu, Ruth Aryeequaye, Lu Wang, Nora Katabi
    Head and Neck Pathology.2018; 12(2): 274.     CrossRef
  • Primary mammary analogue secretory carcinoma of the lung: a case report
    Tao Huang, Jonathan B. McHugh, Gerald J. Berry, Jeffrey L. Myers
    Human Pathology.2018; 74: 109.     CrossRef
  • Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion
    Lisa M. Rooper, Theodoros Karantanos, Yi Ning, Justin A. Bishop, Sarah W. Gordon, Hyunseok Kang
    American Journal of Surgical Pathology.2018; 42(8): 1121.     CrossRef
  • Secretory carcinoma: the eastern Canadian experience and literature review
    David Forner, Martin Bullock, Daniel Manders, Timothy Wallace, Christopher J. Chin, Liane B. Johnson, Matthew H. Rigby, Jonathan R. Trites, Mark S. Taylor, Robert D. Hart
    Journal of Otolaryngology - Head & Neck Surgery.2018;[Epub]     CrossRef
  • Newly described salivary gland tumors
    Alena Skalova, Michal Michal, Roderick HW Simpson
    Modern Pathology.2017; 30: S27.     CrossRef
  • Diagnóstico, tratamiento y seguimiento de un tumor de reciente descripción: el carcinoma análogo secretor de mama (MASC) de glándula salival. A propósito de 2 nuevos casos
    Marina Alexandra Gavín-Clavero, M. Victoria Simón-Sanz, Ana M. López-López, Alberto Valero-Torres, Esther Saura-Fillat
    Revista Española de Cirugía Oral y Maxilofacial.2017; 39(4): 221.     CrossRef
  • Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description
    Bacem A. Khalele, David W. Eisele
    Head & Neck.2017; 39(6): 1243.     CrossRef
  • Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib
    Nicole A. Cipriani, Elizabeth A. Blair, Joshua Finkle, Jennifer L. Kraninger, Christopher M. Straus, Victoria M. Villaflor, Daniel Thomas Ginat
    International Journal of Surgical Pathology.2017; 25(7): 613.     CrossRef
  • A systematic review including an additional pediatric case report: Pediatric cases of mammary analogue secretory carcinoma
    Amanda L. Ngouajio, Sarah M. Drejet, D. Ryan Phillips, Don-John Summerlin, John P. Dahl
    International Journal of Pediatric Otorhinolaryngology.2017; 100: 187.     CrossRef
  • Newly Described Entities in Salivary Gland Pathology
    Alena Skálová, Douglas R. Gnepp, James S. Lewis, Jennifer L. Hunt, Justin A. Bishop, Henrik Hellquist, Alessandra Rinaldo, Vincent Vander Poorten, Alfio Ferlito
    American Journal of Surgical Pathology.2017; 41(8): e33.     CrossRef
  • Mammary Analogue Secretory Carcinoma of Salivary Glands: Diagnostic Pitfall with Distinct Immunohistochemical Profile and Molecular Features
    Oliver Bissinger, Carolin Götz, Andreas Kolk, Henning A. Bier, Abbas Agaimy, Henning Frenzel, Sven Perner, Julika Ribbat-Idel, Klaus Dietrich Wolff, Wilko Weichert, Caroline Mogler
    Rare Tumors.2017; 9(3): 89.     CrossRef
  • Mammary Analogue Secretory Carcinoma of Salivary Gland. A Case Report Emphasizing its Diagnostic Histological, Immunohistochemistry and Molecular Findings
    Monalisa Hui, Shantveer G Uppin, Vamshi Krishna Thamtam, Abhiram Kalle
    International Journal of Head and Neck Surgery.2017; 8(4): 160.     CrossRef
  • A case of mammary analog secretory carcinoma of the lower lip
    Takako Aizawa, Taro Okui, Ken Kitagawa, Yoshikazu Kobayashi, Koji Satoh, Hideki Mizutani
    Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2016; 28(3): 277.     CrossRef
  • Mammary analogue secretory carcinoma of parotid: Is preoperative cytological diagnosis possible?
    Nikita Oza, Kintan Sanghvi, Tanuja Shet, Asawari Patil, Santosh Menon, Mukta Ramadwar, Shubhada Kane
    Diagnostic Cytopathology.2016; 44(6): 519.     CrossRef
  • Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands
    Fernanda Viviane Mariano, Camila Andrea Concha Gómez, Juliana de Souza do Nascimento, Harim Tavares dos Santos, Erika Said Egal, Victor Angelo Martins Montalli, Pablo Agustin Vargas, Oslei Paes de Almeida, Albina Altemani
    Head and Neck Pathology.2016; 10(4): 429.     CrossRef
  • Cytogenetic and immunohistochemical characterization of mammary analogue secretory carcinoma of salivary glands
    Syed A. Khurram, Jemel Sultan-Khan, Neil Atkey, Paul M. Speight
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2016; 122(6): 731.     CrossRef
  • The role of DOG1 immunohistochemistry in dermatopathology
    Keisuke Goto
    Journal of Cutaneous Pathology.2016; 43(11): 974.     CrossRef
  • Extended immunologic and genetic lineage of mammary analogue secretory carcinoma of salivary glands
    Hao Ni, Xue-ping Zhang, Xiao-tong Wang, Qiu-yuan Xia, Jing-huan Lv, Xuan Wang, Shan-shan Shi, Rui Li, Xiao-jun Zhou, Qiu Rao
    Human Pathology.2016; 58: 97.     CrossRef
  • A New Hitherto Unreported Histopathologic Manifestation of Mammary Analogue Secretory Carcinoma: “Masked MASC” Associated With Low-grade Mucinous Adenocarcinoma and Low-grade In Situ Carcinoma Components
    Fredrik Petersson, Michael Michal, Dmitry V. Kazakov, Petr Grossmann, Michal Michal
    Applied Immunohistochemistry & Molecular Morphology.2016; 24(9): e80.     CrossRef
  • Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland
    Min-Shu Hsieh, Yueh-Hung Chou, Shin-Joe Yeh, Yih-Leong Chang
    Virchows Archiv.2015; 467(2): 145.     CrossRef
  • Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study
    Todd M Stevens, Andra O Kovalovsky, Claudia Velosa, Qiuying Shi, Qian Dai, Randall P Owen, Walter C Bell, Shi Wei, Pamela A Althof, Jennifer N Sanmann, Larissa Sweeny, William R Carroll, Gene P Siegal, Martin J Bullock, Margaret Brandwein-Gensler
    Modern Pathology.2015; 28(8): 1084.     CrossRef
  • Aspiration cytology of mammary analogue secretory carcinoma of the salivary gland
    Min Jung Jung, Sang Yoon Kim, Soon Yuhl Nam, Jong-Lyel Roh, Seung-Ho Choi, Jeong Hyun Lee, Jung Hwan Baek, Kyung-Ja Cho
    Diagnostic Cytopathology.2015; 43(4): 287.     CrossRef
  • A Unique Case of a Cutaneous Lesion Resembling Mammary Analog Secretory Carcinoma
    Jennifer Albus, Jacqueline Batanian, Bruce M. Wenig, Claudia I. Vidal
    The American Journal of Dermatopathology.2015; 37(4): e41.     CrossRef
  • Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement
    Hanna Majewska, Alena Skálová, Dominik Stodulski, Adéla Klimková, Petr Steiner, Czesław Stankiewicz, Wojciech Biernat
    Virchows Archiv.2015; 466(3): 245.     CrossRef
  • A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
    Fabrice Projetti, Magali Lacroix-Triki, Elie Serrano, Sebastien Vergez, Béatrice Herbault Barres, Julie Meilleroux, Marie-Bernadette Delisle, Emmanuelle Uro-Coste
    Journal of Oral Pathology & Medicine.2015; 44(4): 244.     CrossRef
  • Mammary Analogue Secretory Carcinoma of Salivary Glands
    Yohei Ito, Kenichiro Ishibashi, Ayako Masaki, Kana Fujii, Yukio Fujiyoshi, Hideo Hattori, Daisuke Kawakita, Manabu Matsumoto, Satoru Miyabe, Kazuo Shimozato, Toshitaka Nagao, Hiroshi Inagaki
    American Journal of Surgical Pathology.2015; 39(5): 602.     CrossRef
  • Cytopathological features of mammary analogue secretory carcinoma-Review of literature
    Maiko Takeda, Takahiko Kasai, Kohei Morita, Mao Takeuchi, Takeshi Nishikawa, Akinori Yamashita, Shinji Mikami, Hiroshi Hosoi, Chiho Ohbayashi
    Diagnostic Cytopathology.2015; 43(2): 131.     CrossRef
  • Mammary Analog Secretory Carcinoma of Salivary Glands
    Justin A. Bishop
    Pathology Case Reviews.2015; 20(1): 7.     CrossRef
  • Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers
    Akihiko Kawahara, Tomoki Taira, Hideyuki Abe, Yorihiko Takase, Takashi Kurita, Eiji Sadashima, Satoshi Hattori, Ichio Imamura, Shinji Matsumoto, Hitomi Fujisaki, Kazunobu Sueyoshi, Jun Akiba, Masayoshi Kage
    Cancer Cytopathology.2015; 123(10): 603.     CrossRef
  • A Case of Mammary Analogue Secretory Carcinoma Arising from Parotid Gland
    Hee Tae Kim, Cha Hee Lee, Han Su Kim, Hae Sang Park
    Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2015; 58(8): 563.     CrossRef
  • WITHDRAWN: A biphasic sessile mass of the buccal mucosa
    Tiffany M. Peters, Jose P. Zevallos, Brent A. Golden, Alice E. Curran
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2015;[Epub]     CrossRef
  • Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics
    Peter P. Luk, Christina I. Selinger, Timothy J. Eviston, Trina Lum, Bing Yu, Sandra A. O’Toole, Jonathan R. Clark, Ruta Gupta
    Pathology.2015; 47(7): 659.     CrossRef
  • A case of mammary analogue secretory carcinoma arising in the submandibular region
    Kotaro ISHII, Koji NAKAMATSU, Koji SATO, Chikashi MINEMURA, Wataru KUMAMARU, Hiroyo YOSHIKAWA
    Japanese Journal of Oral and Maxillofacial Surgery.2015; 61(11): 564.     CrossRef
  • DOG1, p63, and S100 protein: a novel immunohistochemical panel in the differential diagnosis of oncocytic salivary gland neoplasms in fine-needle aspiration cell blocks
    Alessandra C. Schmitt, Ryan McCormick, Cynthia Cohen, Momin T. Siddiqui
    Journal of the American Society of Cytopathology.2014; 3(6): 303.     CrossRef
  • Salivary Gland Tumor “Wishes” to Add to the Next WHO Tumor Classification: Sclerosing Polycystic Adenosis, Mammary Analogue Secretory Carcinoma, Cribriform Adenocarcinoma of the Tongue and Other Sites, and Mucinous Variant of Myoepithelioma
    Douglas R. Gnepp
    Head and Neck Pathology.2014; 8(1): 42.     CrossRef
  • Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance
    Jungweon Shim, Heounjeong Go, Young-Suk Lim, Kyung Chul Moon, Jae Y. Ro, Yong Mee Cho
    Annals of Diagnostic Pathology.2014; 18(6): 363.     CrossRef
  • Mammary analogue secretory carcinoma: Update on a new diagnosis of salivary gland malignancy
    Roshan Sethi, Elliott Kozin, Aaron Remenschneider, Josh Meier, Paul VanderLaan, William Faquin, Daniel Deschler, Robert Frankenthaler
    The Laryngoscope.2014; 124(1): 188.     CrossRef
  • Mammary analog secretory carcinoma of salivary gland in a 5 year old: Case report
    Matthew Keisling, Michael Bianchi, Judy Mae Pascasio
    International Journal of Pediatric Otorhinolaryngology Extra.2014; 9(4): 163.     CrossRef
  • Fine-Needle Aspiration Cytology of Mammary Analog Secretory Carcinoma Masquerading as Low-Grade Mucoepidermoid Carcinoma: Case Report with a Review of the Literature
    Jaya Bajaj, Cecilia Gimenez, Farah Slim, Mohamed Aziz, Kasturi Das
    Acta Cytologica.2014; 58(5): 501.     CrossRef

JPTM : Journal of Pathology and Translational Medicine